IJMS | Free Full-Text | Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats
Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson's Disease | ACS Chemical Neuroscience
Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis - ScienceDirect
The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease
Frontiers | Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
Intranasal LPS-Mediated Parkinson's Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins | PLOS ONE
Frontiers | What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease?
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
PDF) Lipopolysaccharide Animal Models for Parkinson's Disease
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease | Acta Pharmacologica Sinica
Intranasal LPS-Mediated Parkinson's Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins | PLOS ONE
Barbigerone Potentially Alleviates Rotenone-Activated Parkinson's Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines | ACS Omega
DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice
PDF) Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway | Scientific Reports
![PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a63c762e0fa3c8d5b24bb90bbf75a3ae3fff0174/6-Figure1-1.png "PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar")
PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar
Microbes and Parkinson's disease: from associations to mechanisms: Trends in Microbiology
Is Porphyromonas gingivalis involved in Parkinson's disease? | SpringerLink
Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text
Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation: Cell
The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
Frontiers | The Gut–Brain Axis and Its Relation to Parkinson's Disease: A Review
